PMID- 27121079 OWN - NLM STAT- MEDLINE DCOM- 20170216 LR - 20231213 IS - 1791-3004 (Electronic) IS - 1791-2997 (Linking) VI - 13 IP - 6 DP - 2016 Jun TI - MicroRNA‑451 protects against cardiomyocyte anoxia/reoxygenation injury by inhibiting high mobility group box 1 expression. PG - 5335-41 LID - 10.3892/mmr.2016.5192 [doi] AB - High mobility group box 1 (HMGB1) protein serves an important role in myocardial ischemia/reperfusion (I/R) injury. MicroRNAs (miRNAs) are a group of small non‑coding RNAs that regulate numerous signaling pathways involved in myocardial I/R injury. The present study aimed to investigate whether miR‑451 protects against cardiomyocyte anoxia/reoxygenation (A/R) injury by attenuating HMGB1 expression. Neonatal rat ventricular cardiomyocytes were prepared and then subjected to A/R injury. The effect of upregulation or downregulation of miR‑451 on cell viability, apoptosis, superoxide dismutase (SOD) activity, and the expression of cleaved‑caspase‑3 and HMGB1 were measured accordingly. A luciferase assay was performed to further confirm whether miR‑451 can directly recognize the 3'‑untranslated region of HMGB1 in HEK293 cells. The expression of miR‑451 was significantly decreased in the cardiomyocytes during A/R, and upregulation of miR‑451 led to increased miR‑451 expression (P<0.05). Upregulation of miR‑451 significantly attenuated the loss of cardiomyocyte viability (P<0.05) and increased the intracellular levels of SOD during A/R (P<0.05). Furthermore, upregulation of miR‑451 significantly decreased the apoptosis of cardiomyocytes during A/R (P<0.05). The HMGB1 mRNA and protein expression levels were significantly downregulated in the Ad‑miR‑451 group compared with those in the A/R group (P<0.05). In addition, upregulation of miR‑451 reduced its translocation from the nucleus to the cytoplasm. The luciferase assay confirmed that HMGB1 mRNA is a direct target of miR‑451 in cardiomyocytes. In conclusion, the present study suggested that upregulation of miR‑451 could protect against A/R‑induced cardiomyocyte injury by inhibiting HMGB1 expression. FAU - Xie, Jing AU - Xie J AD - Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, Hubei 430060, P.R. China. FAU - Hu, Xiaorong AU - Hu X AD - Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, Hubei 430060, P.R. China. FAU - Yi, Chunfeng AU - Yi C AD - Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, Hubei 430060, P.R. China. FAU - Hu, Gangying AU - Hu G AD - Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, Hubei 430060, P.R. China. FAU - Zhou, Xiaoya AU - Zhou X AD - Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, Hubei 430060, P.R. China. FAU - Jiang, Hong AU - Jiang H AD - Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, Hubei 430060, P.R. China. LA - eng PT - Journal Article DEP - 20160426 PL - Greece TA - Mol Med Rep JT - Molecular medicine reports JID - 101475259 RN - 0 (HMGB1 Protein) RN - 0 (Hbp1 protein, rat) RN - 0 (MIRN451A microRNA, rat) RN - 0 (MicroRNAs) SB - IM MH - Animals MH - *Gene Expression Regulation MH - HEK293 Cells MH - HMGB1 Protein/*biosynthesis MH - Humans MH - MicroRNAs/*metabolism MH - Myocardial Reperfusion Injury/*metabolism/pathology/*prevention & control MH - Myocytes, Cardiac/*metabolism/pathology MH - Rats EDAT- 2016/04/29 06:00 MHDA- 2017/02/17 06:00 CRDT- 2016/04/29 06:00 PHST- 2015/04/30 00:00 [received] PHST- 2016/01/29 00:00 [accepted] PHST- 2016/04/29 06:00 [entrez] PHST- 2016/04/29 06:00 [pubmed] PHST- 2017/02/17 06:00 [medline] AID - 10.3892/mmr.2016.5192 [doi] PST - ppublish SO - Mol Med Rep. 2016 Jun;13(6):5335-41. doi: 10.3892/mmr.2016.5192. Epub 2016 Apr 26.